Biomedical Engineering Reference
In-Depth Information
Rao AG, Yamada M (1988) Forecasting with a repeat purchase model. Manag Sci 34(6):734-752
Rothaermel FT (2001a) Complementary assets, strategic alliances, and the incumbent's advantage:
an empirical study of industry and fi rm effects in the biopharmaceutical industry. Res Policy
30:1235-1251
Rothaermel FT (2001b) Incumbent's advantage through exploiting complementary assets via
interfi rm cooperation. Strat Manag J 22(6/7):687-699
Rothaermel FT, Deeds DL (2006) Alliance type, alliance experience and alliance management
capability in high-technology ventures. J Bus Venturing 21:419-460
Shan WJ, Walker G, Kogut B (1994) Interfi rm cooperation and startup innovation in the biotech-
nology industry. Strat Manag J 15:387-394
Shankar V (1999) New product introduction and incumbent response strategies: their interrelation-
ship and the role of multimarket contract. J Market Res 36:327-344
Shankar V (2008) Strategic marketing decision models for the pharmaceutical industry. In:
Wierenga B (ed) Handbook of marketing decision models. Springer, New York
Shankar V, Carpenter G, Krishnamurthi L (1998) Late mover advantage: how innovative late
entrants outsell pioneers. J Market Res 35:54-70
Shankar V, Carpenter G, Krishnamurthi L (1999) The advantages of entry in the growth stage of
the product life cycle: an empirical analysis. J Market Res 36:269-276
Simonet D (2002) Licensing agreements in the pharmaceutical industry. Int J Med Market
2(4):329-341
Sorescu AB, Chandy RK, Prabhu JC (2003) Sources and fi nancial consequences of radical innova-
tion. J Market 67:82-102
Stremersch S, van Dyck W (2009) Marketing of the life sciences: a new framework and research
agenda for a nascent fi eld. J Market 73(July):4-30
Stuart TE, Hoang H, Hybels RC (1999) Interorganizational endorsements and the performance of
entrepreneurial ventures. Adm Sci Q 44:315-349
Thomke S, Kuemmerle W (2002) Asset accumulation, interdependence and technological change:
evidence from pharmaceutical drug discovery. Strat Manag J 23(7):619-635
Vakratsas D, Kolsarici C (2008) A dual-market diffusion model for a new prescription pharmaceu-
tical. Int J Res Market 25:282-293
Wuyts S, Dutta S (2008) Licensing exchange—insights from the pharmaceutical industry. Int J Res
Market 25:273-281
Search WWH ::
Custom Search